Variant report
Variant | nsv977264 |
---|---|
Chromosome Location | chr13:88718070-88722375 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1529361 | chr13:88720825-88720826 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs536409351 | chr13:88720826-88720827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574739209 | chr13:88720855-88720856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555150494 | chr13:88720885-88720886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs180677968 | chr13:88720886-88720887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560459992 | chr13:88720976-88720977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534520783 | chr13:88721010-88721011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563092794 | chr13:88721029-88721030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527516009 | chr13:88721031-88721032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs145289649 | chr13:88721036-88721037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs367874248 | chr13:88721039-88721040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544269997 | chr13:88721043-88721044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562560739 | chr13:88721048-88721049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574593800 | chr13:88721052-88721053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563006514 | chr13:88721057-88721058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542489332 | chr13:88721060-88721061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs71101050 | chr13:88721069-88721070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs531316000 | chr13:88721081-88721082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185938648 | chr13:88721119-88721120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73578158 | chr13:88721148-88721149 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs74984360 | chr13:88721154-88721155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1855392 | chr13:88721178-88721179 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs564271758 | chr13:88721272-88721273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs377359520 | chr13:88721286-88721287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs192473953 | chr13:88721290-88721291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143833511 | chr13:88721305-88721306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1855391 | chr13:88721307-88721308 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs78354305 | chr13:88721314-88721315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530158097 | chr13:88721331-88721332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566817372 | chr13:88721353-88721354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs115302900 | chr13:88721379-88721380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs111227540 | chr13:88721398-88721399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs534154855 | chr13:88721410-88721411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559198808 | chr13:88721414-88721415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs36095716 | chr13:88721437-88721438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71823570 | chr13:88721438-88721439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs398056672 | chr13:88721440-88721441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187088356 | chr13:88721543-88721544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34308679 | chr13:88721544-88721545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs398044120 | chr13:88721545-88721546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187029212 | chr13:88721551-88721552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs201096578 | chr13:88721580-88721581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574556436 | chr13:88721637-88721638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1855390 | chr13:88721663-88721664 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs549984542 | chr13:88721677-88721678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553614600 | chr13:88721686-88721687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs572203168 | chr13:88721751-88721752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191449256 | chr13:88721755-88721756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564000467 | chr13:88721770-88721771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs73578160 | chr13:88721786-88721787 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Mental retardation | 17847001 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:88720800-88721200 | Enhancers | HSMM | muscle |
2 | chr13:88721000-88721400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr13:88721400-88723800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |